Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 238 of 5804
-
New drug could help kidney transplant patients avoid rejection
Disease control Recruiting nowThe goal of this clinical trial is to learn if siplizumab can prevent rejection of a kidney transplant in adult participants with end stage kidney disease. The main questions it aims to answer are: How many adverse events do participants receiving two different doses of siplizum…
Phase: PHASE2 • Sponsor: Nefro Avillion Clinical Development, LLC • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Smarter heart pacing could cut hospital stays for heart failure patients
Disease control Not yet recruitingThe goal of this observational study is to evaluate the long-term clinical outcomes of physiologic cardiac resynchronization therapy (CRT) using conduction system pacing strategies compared with conventional biventricular CRT in patients with heart failure with reduced ejection f…
Sponsor: University of Pecs • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Double-Targeting antibody takes on Hard-to-Treat throat cancer
Disease control Recruiting nowThis study is to determine the activity and tolerability of JS207 as a single agent and in combination cohort with chemotherapy. This is an open-labelled, phase Ib/II study of JS207 in patients with previously treated recurrent or metastatic nasopharyngeal carcinoma. The study wi…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a painkiller stop the cough that Won't quit in lung fibrosis?
Symptom relief Recruiting nowThe primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fibrosis (IPF).
Phase: PHASE3 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New weight loss pill enters final testing phase in china
Disease control Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study aimed at evaluating the efficacy, safety, and pharmacokinetic (PK) characteristics of DA-302168S tablets in overweight or obese participants in China.
Phase: PHASE3 • Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
Disease control Recruiting nowThis study will evaluate the application of a metaverse-based surgical simulation platform in extracranial-intracranial (EC-IC) bypass surgery. The study population will include patients with moyamoya disease or chronic cerebral ischemia who are scheduled to undergo EC-IC bypass …
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New lung drug faces off against standard treatment in major trial
Disease control Recruiting nowThis is a study for adults with a lung disease called idiopathic pulmonary fibrosis. The main purpose of this study is to look at how well deupirfenidone improves lung function and how safe it is for people with idiopathic pulmonary fibrosis (IPF) when compared with pirfenidone. …
Phase: PHASE3 • Sponsor: PureTech • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New inhaled drug could ease breathing for PAH patients
Disease control Recruiting nowThe primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New cocktail aims to tame myeloma without transplant
Disease control Not yet recruitingThis study is to evaluate the combination of isatuximab, iberdomide, bortezomib, and dexamethasone in newly diagnosed multiple myeloma participants who are transplant ineligible or not intended for upfront transplant. The names of the study drugs used in this research study are:…
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to keep hepatitis b in check
Disease control Not yet recruitingThis is a multicenter, single-arm, open-label, phase IIIb extension clinical trial designed to evaluate the long-term safety and tolerability of GST-HG141 (nerlecovir, 50 mg BID) in combination with nucleos(t)ide analogues (NAs) in patients with chronic hepatitis B (CHB) who comp…
Phase: PHASE3 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New daily pill aims to tackle Hard-to-Treat lymphoma
Disease control Not yet recruitingThis is an open-label, first-in-human dose escalation and dose expansion Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HP-002 in patients with relapsed or refractory B-Cell Non-Hodgkin Lymphoma This study consists of …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Helioson Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Precision radiotherapy may buy time for men with spreading prostate cancer
Disease control Recruiting nowPSMA-OLIGO-PRO is a multicenter ambispective observational real-world registry evaluating outcomes after PSMA PET-guided progression-directed radiotherapy for oligoprogressive prostate cancer. The registry includes retrospectively identified patients treated before June 26, 2026 …
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New PET tracer aims to reveal hidden myeloma spots
Diagnosis Not yet recruitingThis is a prospective, single-center, single-arm Phase I study evaluating GPRC5D-targeted PET/CT imaging in patients with plasma cell disorders, including multiple myeloma. Participants will undergo GPRC5D-targeted PET/CT, 18F-FDG PET/CT, and 68Ga-BCMA PET/CT within 5 days whene…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Old drug, new hope? emetine trial targets dengue deaths
Disease control Not yet recruitingThe goal of this study is to evaluate the efficacy and safety of emetine administered orally for symptomatic patients aged 18-65 years infected with the dengue virus. The main questions it aims to answer are: 1. Does emetine reduce 28-day mortality or progression to severe dengu…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Experimental CAR-T therapy targets tough T-Cell cancers
Disease control Recruiting nowOverall Introduction This single-arm, open-label clinical trial aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CXCR4-enabled CCR9 chimeric antigen receptor T-cell injection (CXCR4 CCR9 CAR-T) in patients with relapsed or refractory T-lymphobl…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo aims to stop lung cancer recurrence in High-Risk patients
Disease control Not yet recruitingThe purpose of the study is to compare the efficacy and safety of SYS6010 in combination with anti-PD-(L)-1 monoclonal antibody vs. anti-PD-(L)-1 monoclonal antibody as adjuvant therapy for patients with. with completely resected stage II-IIIB, actionable genomic alterations (AGA…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Blood filters aim to reverse organ failure in septic shock
Disease control Not yet recruitingHemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation. A Pilot Multicenter Randomized Controlled Trial. The goal of this clinical trial is the estimation of the efficacy and safety of hemoadsorption procedures (LPS (Lipopolysaccharide) and inflammatory medi…
Phase: NA • Sponsor: Moscow Multidisciplinary Clinical Center "Kommunarka" • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New vaccine aims to tackle multiple salmonella strains at once
⭐️ VACCINE ⭐️ Not yet recruitingThe current clinical study will evaluate the GVGH Quadrivalent Pan-Salmonella vaccine for the first time in healthy adults in Africa. The purpose of the current Phase 1 study is to evaluate the safety, reactogenicity, and the immune response induced by the Pan-Salmonella vaccine.
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
Sparing lymph nodes during radiation may boost immune attack on rectal cancer
Disease control Recruiting nowSafety and efficacy of Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab versus Short-course Radiotherapy plus Chemotherapy as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer. Com…
Phase: PHASE2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Less invasive heart valve replacement put to the test against Open-Heart surgery
Disease control Not yet recruitingThe study is a multicenter, randomized superiority trial of standard of care therapies for severe aortic stenosis (AS) in patients with a bicuspid aortic valve (BAV). The two primary comparators in this study are: Transcatheter Aortic Valve Replacement (TAVR), and Surgical Aorti…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC